Month: June 2024

Survival analyses with CNM-Au8 30 mg treatment compared to matched PRO-ACT controls demonstrated improved survival up to 3.5 years post-baseline (hazard ratio: 0.431, p=0.0002) Average of 28% NfL reduction observed in an NfL responder subset (geometric mean ratio, change at Week 76 post-baseline: 0.72, p

TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) Forsys is pleased to be able to release the results of its metallurgical column leaching test work for its Norasa Uranium project (“Norasa Project”1) together with details of its work plan for further optimising heap leach conditions and ore-sorting testwork. HighlightsCompleted metallurgical test work supports utilizing heap leaching to recover uranium at Norasa. A total of 16 metallurgical column leach tests have been completed. Various test conditions were assessed, covering initial scouting tests aimed at evaluating the impact of binder addition, higher irrigation rates and grind size on recoveries, leach kinetics and acid consumption. Uranium extraction rates of up to 87% (crushed with a conventional...

Expansion into fastest-selling Playstation title ever provides access to new users and growth opportunities LOS ANGELES, June 18, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a leading gaming and media company, is pleased to announce that its data-driven and insights platform, U.GG, has expanded into Helldivers 2. Helldivers 2 marks U.GG’s first expansion outside of the Blizzard and Riot ecosystems, bringing their data-driven insights to a new community of users and the total number of games covered by the platform to five, together with League of Legends, World of Warcraft, Valorant, and Teamfight Tactics. The expansion is also the second to leverage U.GG’s curated content management system initially developed for U.GG’s expansion into TeamFight Tactics announced on...

NEW YORK, June 18, 2024 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aixia Group AB (Spotlight Stock Market: AIXIA B; OTCQX: AIXAF), an information technology company, has qualified to trade on the OTCQX® Best Market. Aixia Group AB begins trading today on OTCQX under the symbol “AIXAF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX,...

FDA has placed a partial clinical hold on ZN-c3-001, DENALI and TETON monotherapy studies of azenosertib Monotherapy data to be presented in the second half of 2024 Conference call to be held today, June 18, 8:00 am ET SAN DIEGO, June 18, 2024 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the following studies of azenosertib: the Phase 1 ZN-c3-001 dose-escalation study in solid tumors, the Phase 2 ZN-c3-005 (DENALI) study in platinum-resistant ovarian cancer (PROC) and the Phase 2 ZN-c3-004 (TETON) study in uterine serous carcinoma...

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (“CLC” or the “Company”) (CSE: CLC) is pleased to confirm that further to its news releases dated April 3, 2024, April 17, 2024, May 1, 2024, May 15, 2024, May 29, 2024 and June 3, 2024, the Company has filed on SEDAR its audited financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended November 30, 2023 (the “Annual Filings”). The Annual Filings can be obtained on the Company’s SEDAR profile at www.sedarplus.ca. As a consequence of the Annual Filings, the Company expects that the management cease trade order formerly granted on April 3, 2024, by applicable securities regulatory authorities, will be revoked and that directors and...

BOUCHERVILLE, Québec, June 18, 2024 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC. (TSXV: LSL) (“the Company” or “LSL Pharma”), a Canadian integrated pharmaceutical company, is pleased to announce the completion of the acquisition of Virage Santé (“Virage”), a company specializing in the manufacturing and marketing of natural health products (“NHPs”), based in Lévis, Quebec. This acquisition increases LSL Pharma’s contract development and manufacturing activities, while creating synergies with its subsidiary LSL Laboratory Inc. (“LSL”). The purchase price of $2.5 million was paid in cash for the acquisition of Virage. The transaction includes an 8,000 sq ft manufacturing plant. The acquisition of Virage will boost LSL Pharma`s revenues by 15-20% annually, as well as broaden...

RENO, Nev., June 18, 2024 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries®, today announced a partnership with Meyer Distributing, a leading distributor of specialty products across North America. Through this collaboration, Dragonfly Energy will leverage Meyer Distributing’s extensive network of over 100 locations across North America to deliver Battle Born Batteries to new business-to-business customers in the recreational vehicle (“RV”) and surrounding industries. “We are thrilled to partner with Meyer Distributing to continue to strengthen our presence within the RV and adjacent markets. We believe this partnership has the potential to empower RV and Overland enthusiasts...

Boston Scientific to acquire Silk Road Medical for $27.50 per share in cash SUNNYVALE, Calif., June 18, 2024 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (“Silk Road”) (NASDAQ:SILK), a leading minimally invasive medical device company for carotid artery procedures, announced today it has entered into a definitive agreement to be acquired by Boston Scientific Corporation (“Boston Scientific”) (NYSE: BSX), a global medical technology leader, for $27.50 in cash per share, representing an equity value of approximately $1.26 billion. The per share price represents an approximate 38% premium to the volume-weighted average share price of Silk Road Medical’s common stock over the past 60 days. The board of directors of Silk Road has unanimously approved the transaction and recommend that Silk Road stockholders adopt the merger agreement....

After a Reduction in Surgical Site Infection (SSI) Rates During COVID, Rates are Now Increasing, Signaling a Return to Pre-COVID Levels Known Procedure and Patient Risk-Factors Significantly Increase the Risk of SSIs and Impact Payer Costs Approximately 250 Patients of a Planned Total of 600 Subjects Currently Enrolled in SHIELD II Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in the First Quarter of 2025 PETACH TIKVA, Israel, June 18, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today hosted a virtual Key Opinion Leader event discussing the significant unmet medical need in the prevention of surgical site infections (SSIs). The Company...